You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

18F-2-fluoro-2-deoxy-D-glucose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer, Breast Carcinoma, Metastatic Breast Cancer Trial in New York (18F-FDG PET/CT, [18F]-Fluoro-2-Deoxy-D-Glucose and

Recruiting
  • Breast Cancer
  • +4 more
  • 18F-FDG PET/CT
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 17, 2023

Glioma Trial in Portland (Fludeoxyglucose F-18, Gadoterate Meglumine, Contrast-enhanced Magnetic Resonance Imaging)

Not yet recruiting
  • Glioma
  • Fludeoxyglucose F-18
  • +3 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jun 30, 2023

Lung Carcinoma Trial in Philadelphia (Fludeoxyglucose F-18, Positron Emission Tomography, Computed Tomography)

Recruiting
  • Lung Carcinoma
  • Fludeoxyglucose F-18
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University Hospital
Mar 7, 2023

Brain Cancer Trial in Salt Lake City ([18F]fluoro-2-deoxy-D-glucose (FDG),

Recruiting
  • Brain Cancer
  • [18F]fluoro-2-deoxy-D-glucose (FDG)
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jan 3, 2023

Endometriosis Trial in Saint-Denis, Saint-Pierre (PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose)

Not yet recruiting
  • Endometriosis
  • PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose) (radiolabel)
  • Saint-Denis, France
  • +1 more
Mar 1, 2022

Solitary Pulmonary Nodule, Oncology, 18F-2-fluoro-2-deoxy-D-glucose Trial (18F-2-fluoro-2-deoxy-D-glucose)

Not yet recruiting
  • Solitary Pulmonary Nodule
  • +3 more
  • 18F-2-fluoro-2-deoxy-D-glucose
  • (no location specified)
Nov 2, 2020

Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Duarte (procedure, other, device)

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Computed Tomography
  • +3 more
  • Duarte, California
    City of Hope Medical Center
May 3, 2023

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Positive Breast Carcinoma Trial (drug,

Not yet recruiting
  • Anatomic Stage II Breast Cancer AJCC v8
  • +3 more
  • (no location specified)
Jan 24, 2023

Metastatic Malignant Tumor, Metastatic Malignant Tumor in the Bone Trial in Houston (Fludeoxyglucose F-18, Magnetic Resonance

Active, not recruiting
  • Metastatic Malignant Neoplasm
  • Metastatic Malignant Neoplasm in the Bone
  • Fludeoxyglucose F-18
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Prostate Cancer Trial in New York (positron emission tomography, fludeoxyglucose F 18, methionine C 11)

Active, not recruiting
  • Prostate Cancer
  • positron emission tomography
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 18, 2022

Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Malignant Tumor in the Spine Trial in Houston (Computed Tomography,

Recruiting
  • Metastatic Head and Neck Squamous Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Spine
  • Computed Tomography
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 13, 2022

Lung Carcinoma, Solitary Pulmonary Nodule, Cigarette Smoking Behavior Trial in Nashville (procedure, radiation, drug, other)

Completed
Has Results
  • Lung Carcinoma
  • +2 more
  • Computed Tomography
  • +5 more
  • Nashville, Tennessee
  • +1 more
Oct 17, 2022

Brain Glioblastoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18, Magnetic Resonance Imaging)

Completed
  • Brain Glioblastoma
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Breast Cancer Trial in Salt Lake City ([18F]Flutemetamol, [18F]fluoro-2-deoxy-D-glucose (FDG), Functional Magnetic Resonance

Recruiting
  • Breast Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Feb 3, 2022

Cigarette Smoker, Current Smoker, Former Smoker Trial in Palo Alto (Computed Tomography, Fludeoxyglucose F-18, Fluorine F 18

Recruiting
  • Cigarette Smoker
  • +4 more
  • Computed Tomography
  • +3 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Jun 16, 2022

Breast Carcinoma, Fallopian Tube Carcinoma, Ovarian Carcinoma Trial in Houston (Computed Tomography, Fludeoxyglucose F-18,

Recruiting
  • Breast Carcinoma
  • +7 more
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 24, 2022

Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Los Angeles (procedure, drug, other)

Not yet recruiting
  • Recurrent Multiple Myeloma
  • Refractory Multiple Myeloma
  • Bone Marrow Aspiration
  • +10 more
  • Los Angeles, California
    Melanie Ayala Ceja
Jul 10, 2023

Malignant Tumor of Head and Neck, Locally Advanced Malignant Tumor Trial in France (Positron emission tomography, radiochemo)

Completed
  • Malignant Neoplasm of Head and Neck
  • Locally Advanced Malignant Neoplasm
  • Positron emission tomography
  • radiochemotherapy
  • Brest, France
  • +4 more
Jul 26, 2021

Recurrent DLBCL, Refractory DLBCL Trial in Houston (Chemotherapy, Computed Tomography, Fludeoxyglucose F-18)

Completed
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Active, not recruiting
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Los Angeles, California
  • +3 more
Nov 16, 2022

Glioblastoma Trial in Los Angeles (Computed Tomography, Fludeoxyglucose F-18, Positron Emission Tomography)

Recruiting
  • Glioblastoma
  • Computed Tomography
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Feb 2, 2022

Malignant Tumor Trial in Salt Lake City ([F-18]fluorodeoxyglucose, [F-18]fluorothymidine, Positron Emission Tomography)

Terminated
Has Results
  • Malignant Neoplasm
  • [F-18]fluorodeoxyglucose
  • +3 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute/University of Utah
Sep 20, 2021

Lung Adenocarcinoma Trial in Los Angeles (drug, procedure, other)

Recruiting
  • Lung Adenocarcinoma
  • Los Angeles, California
    Yesenia Calzada
Jan 27, 2023

Neuroendocrine Tumors Trial in Meldola (177Lu-DOTATATE 25.9 GBq activity, 177Lu-DOTATATE 18.5 GBq activity)

Active, not recruiting
  • Neuroendocrine Tumors
  • 177Lu-DOTATATE 25.9 GBq activity
  • 177Lu-DOTATATE 18.5 GBq activity
  • Meldola, FC, Italy
    Irst Irccs
Feb 25, 2021

Immune Checkpoint Inhibitor-Related Myocarditis

Recruiting
  • Myocarditis Acute
  • Computed Tomography
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 21, 2021